Category: CannabisNewsWire Release

420 with CNW – Congress Passes Measure Allowing Military Personnel to Use CBD

When the 2018 Farm Bill legalized industrial hemp and its derivatives, no one knew just how big cannabidiol (“CBD”) would get. Flush with medical properties, CBD has quickly become a go-to compound for people seeking a natural alternative to pharmaceuticals. However, despite being federally legalized, several military branches have in the past few months issued statements stating that service members were not permitted to use CBD products. In response, Rep. Tulsi Gabbard, a military veteran, and former 2020 Democratic presidential candidate sponsored an amendment that would allow military service members to use products containing hemp and its derivatives.

Approved by the House of Representatives on Monday, the amendment stipulates that the “Secretary of Defense may not prohibit, on the basis of a product containing hemp or any ingredient derived from hemp, the possession, use or consumption of such a product by a member of the Armed Forces.” This is only applicable as long as the crop meets the federal definition of hemp (less than 0.3% THC) and “such possession, use, or consumption is in compliance with applicable Federal, State, and Local law.”

Gabbard’s amendment will address notices from several military branches instructing their service members to abstain from using CBD. For instance, the Department of Defense (DOD) announced a policy barring all active service members from using hemp products, including CBD, in February. The DOD acknowledged that while hemp was legal, the risk of exposure to excess THC was too great.

The Air Force and the Navy as well have informed their members that they are barred from using hemp-derived CBD, no matter its legality. Although NASA isn’t part of the military, it has also warned its employees that CBD products could contain excess levels of THC that could cost them their job if they fail a drug test. This aversion to CBD products can be traced back to a July 24 government wide-memo asking agencies to update their employees about CBD.

The notice by the Substance Abuse and Mental Health Services Administration (“SAMHSA”) stated that although the 2018 Farm Bill legalized hemp-derived CBD, “the Food and Drug Administration does not certify levels of THC in the products. The agency stated that due to the lack of regulatory oversight from the FDA, “federal workers and those with security clearances who test positive for THC metabolites will be penalized, regardless of whether they thought they were taking CBD alone.”

Rep. Gabbard’s amendment was passed in an en bloc passage including dozens of other non-cannabis amendments to the National Defense Authorization Act (“NDAA”), and it has been attached to the House version of the NDAA.

Cannabis sector players like Pure Extracts Corp. are probably waiting to see the fate of the amendment once it gets to the floor of the U.S. Senate.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

420 with CNW – FDA Finally Releases Cannabis Research Guidelines

In December 2018, Congress passed the 2018 Farm Bill, a landmark legislation that legalized the cultivation and sale of industrial hemp and it’s derivatives after decades of prohibition. Cannabidiol, a hemp extract with medical capabilities, quickly grew in popularity, resulting in an unregulated market worth millions of dollars in sales. For months, advocates, stakeholders, and some lawmakers have urged the U.S. Food and Drug Administration (“FDA”) to create a comprehensive regulatory structure for the industry.

On Tuesday, the agency finally released draft guidance on developing cannabis-based drugs, weeks after the White House announced that it had finished reviewing the draft guidance. The published document states that the guidance is “limited to the development of human drugs and does not cover other FDA regulated products.” As the FDA is still developing guidelines that would allow CBD to be marketed and sold as a food item or supplement, the draft document is meant to provide guidance for drug manufacturing.

“A range of stakeholders have expressed interest in the development of drugs that contain cannabis and other compounds found in cannabis. Recent legislative changes have also opened new opportunities for cannabis clinical research. As that body of research progresses and grows, the FDA is working to support drug development in this area,” says FDA Principal Deputy Commissioner Amy Abernethy. The legislative change she refers to is the 2018 Farm Bill which legalized industrial hemp with less than 0.3% THC. Thus, researchers can use industrial hemp from any source as long as it doesn’t have excess THC, not just from the University of Mississippi, the country’s only federally authorized marijuana manufacturer.

The new document stresses on THC testing, stating that sponsors and investigators may find it useful to calculate the level of delta-9 THC in their proposed investigational drug product early in the development process to gain insight into the potential control status of their product. “Regardless of whether cannabis or a cannabis-derived compound meets the definition of hemp, sponsors and applicants should work with reliable laboratories for analytical testing.”

It also gives step by step guidance on how to test for THC on a dry weight basis according to the FDA’s standards. In a Federal Register notice accompanying the new draft guidance, the agency asked for comments from the public on their recommended approach to testing for THC. The FDA has opened a 60-day comment period for stakeholders to offer their opinions on the proposed research guidelines.

It would be great to hear what the initial reactions of entities like VIVO Cannabis Inc. (TSX.V: VIVO) (OTCQX: VVCIF) are regarding the research guidelines published by the FDA.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

420 with CNW – Activists Put Pressure on Mexican Lawmakers to Legalize Recreational Marijuana

The past few years have been great for cannabis. Advanced research into its effects on the body that has found it has plenty of medical benefits, coupled with changing attitudes towards the plant, have pushed it more into the mainstream. As a result, plenty of territories have passed legislation allowing either recreational or medical marijuana within their borders. Many more jurisdictions have cannabis legalization on the books or they are at least considering it.

In Mexico, activists have demanded that the Senate include the legalization of recreational cannabis in the next special session that starts on July 29. This comes after the Mexican Cannabis Movement accused the Senate of possible contempt of a 2018 ruling by the Supreme Court of Justice of the Nation (“SCJN”). The court ruled that an absolute ban on the recreational use of marijuana was unconstitutional and gave Congress until December 15 to regulate public consumption of marijuana. However, according to activists, legislators have consistently failed to do that.

“We see constant delay, a delay in this legislation, now there is already one more extension, until Dec 15, and there is a Senator who wants to postpone the ruling even more under the excuse of the COVID-19 pandemic,” says Leopoldo Rivera, coordinator of the movement. They are holding a demonstration in front of the Senate in downtown Mexico City, where they have planted 420 marijuana plants of up to 2.5 meters tall. The activists want legislators to pass a law that upholds four core values: free personal or associated cultivation, simple free possession, dignified treatment, and public spaces for safe, responsible, and regulated consumption.

“We decided to start this movement of planting weed, and planting ourselves as citizens, as users of cannabis and as responsible citizens against a law that clearly does not do justice, that clearly criminalizes, that is clearly useless,” Rivera says. This March, the senate discussed a marijuana regulation law that would allow people to possess up to 28 grams of marijuana, and wouldn’t criminalize cultivating or using cannabis for medical purposes. However, it was met with opposition from activists who claimed it did not comply with the ruling by the SCJN and favored the interests of private companies.

“We’ve been here more than five months and only four months and only four senators have come down. Who do they legislate for? What they are proposing is a cosmetic change, which is not going to solve the problems of unconstitutionality pointed out by the Supreme Court,” says Rivera, adding that the Supreme Court shouldn’t grant any extensions to the Mexican Senate. “The police are mistreating the people, they are mistreating us, they are mistreating the citizens, they arrest them even when they are not consumers to extort them, to deprive them of their freedom, and that goes against the Mexican constitution.”

It would be interesting to hear what thoughts cannabis companies like Sugarmade, Inc. (OTCQB: SGMD) have about the bumpy ride that marijuana legalization is taking despite a categorical ruling from the Supreme Court of the country about the topic.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

420 with CNW – Third-Party Presidential Nominees Push for Marijuana Legalization

With everything that’s been going on for the past six months, from a global pandemic that’s crippled the economy to the protests against police brutality raging across the country, it’s easy to forget that the November ballot is fast approaching. The ballot may very well be a turning point for the cannabis industry. For starters, the Democratic Party made it clear that if it clinches Congress and the White House this coming November, it will make decriminalizing marijuana one of its top priorities, despite presumptive Democratic presidential nominee Joe Biden’s views on the matter.

The presidential nominees for both the Libertarian and Green Parties also support broader drug reform, including legalizing marijuana. During an interview with C-SPAN this month, Libertarian pick Jo Jorgensen said that the biggest problem we have right now isn’t drugs but drug prohibition. “Now, do drugs and alcohol cause problems? Of course, they do. However, they’d be much more manageable if it were legal. What’s the difference between me drinking bourbon in my home and somebody else smoking marijuana in their own home? If there is no victim, there is no crime,” she says.

In a statement released on Twitter, she said that the U.S. prison population jumped from 350,000 to 2.3 million in just 30 years due to ‘Draconian sentence lengths, mandatory minimums, and an increase in the number of drug laws which creates more ‘crimes’.” Ending the failed drug war would be a top priority if elected as it has led to the highest incarceration rate in the world. On day 1, I would pardon ALL nonviolent, victimless offenders in federal prison. If there was no victim, there is no crime.”

During a speech delivered remotely for the Green Party National Convention, Green nominee Howie Hawkins said that drug reform could be a tool to combat mass incarceration. “We’ve got to treat drug abuse as a health problem. You should legalize marijuana and decriminalize the hard drugs like Portugal did. Instead of just throwing people in prison and building the biggest prison industrial system in the world, which Joe Biden had a lot to do with as he wrote the legislative architecture for that as chair of the Senate Judiciary Committee, we should be treating drug addiction as a health problem, not a criminal problem.”

“One of the central changes to policing is to end the war on drugs. 20% of incarcerated people in the U.S. are locked up due to a drug offense. We need to legalize marijuana, decriminalize other drugs, and make treatment readily available like Portugal did.”

Industry watchers say cannabis sector players like VIVO Cannabis Inc. (TSXV: VIVO) (OTCQX: VVCIF) may not put a lot of stock in what these other presidential nominees say since they don’t command a huge following among voters, and can hardly sway the direction of drug policy at the federal level.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

CannabisNewsBreaks – Sugarmade, Inc. (SGMD) Announces Publication of New 8K Highlighting Specific BudCars Investment Information

Sugarmade (OTCQB: SGMD), today announces the publication of a new Form 8K Current Report filing (the “8K”) with the United States Securities and Exchange Commission (the “SEC”). According to the update, the 8K highlights specific information about the Company’s investment position in Indigo Dye Group, Inc., which conducts business as a cannabis delivery service under the name “BudCars.” The 8K also contains current information about the performance of BudCars in terms of gross receipts from operations during the three months ended June 30, 2020.

To view the full press release, visit http://cnw.fm/82Kvr

About Sugarmade, Inc.

Sugarmade is a product and branding marketing company investing in operations and technologies with disruptive potential. More information on Sugarmade can be accessed at: www.Sugarmade.com. Sugarmade sees opportunities in business operations that combine the best areas of on-demand consumer distribution with certain areas of synergistic manufacturing and packaging to create a business model that capitalizes on the many changes in the cannabis industry. The company has made agreements with several market participants, which will be announced in 2020. The company views these opportunities as scalable and capable of producing strong revenue growth for the company.

NOTE TO INVESTORS: The latest news and updates relating to SGMD are available in the company’s newsroom at http://cnw.fm/SUGAR

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive SMS text alerts from CannabisNewsWire, text “CANNABIS” to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

CannabisNewsBreaks – Cannabis Global, Inc. (MCTC) Enters Estimated $10B Cannabis Market Through Strategic Agreement with Whisper Weed

Cannabis Global (OTC: MCTC), a cannabinoid and hemp extract science-forward company developing infusion and delivery technologies, today announced the closing of a definitive agreement to enter the fast-growing California cannabis delivery market. According to the update, Whisper Weed, Inc. and Cannabis Global have, under the executed agreement, created a new California Corporation to be named CGI Whisper W, Inc., which will provide management services for the delivery entity. CGI Whisper W, Inc, will receive 51% of the new entity’s profits, which will be recognized by Cannabis Global as income. “The delivery sector is the hottest area of the California cannabis business and we are very pleased to have a seat at the table,” Arman Tabatabaei, CEO of Cannabis Global, stated in the news release. “We not only will be able to grow our revenue base relative to direct delivery, but we also see Whisper Weed as a perfect platform to launch our infusion technologies in the regulated marketplace. With the deal closing, we are already in the process of adding other delivery platforms and other businesses to our overall portfolio.”

To view the full press release, visit http://cnw.fm/rwedO

About Cannabis Global, Inc.

Cannabis Global is a Nevada registered, fully reporting and audited publicly traded company. With the hemp and cannabis industries moving very quickly and with a growing number of market entrants, Cannabis Global plans to concentrate its efforts on the middle portions of the hemp and cannabis value chain. The Company plans to actively pursue R&D programs and productization for exotic cannabinoid isolation, bioenhancement of cannabinoids and polymeric solid nanoparticles and nanofibers for addition into consumer products and for dermal application. The Company was reorganized during June of 2019 and announced its intent to enter the fast-growing cannabis sector. The Company is headed and managed by a group of highly experienced cannabis industry pioneers and entrepreneurs. For more information, visit the Company’s website at www.CannabisGlobalInc.com.

NOTE TO INVESTORS: The latest news and updates relating to MCTC are available in the company’s newsroom at http://cnw.fm/MCTC

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive SMS text alerts from CannabisNewsWire, text “CANNABIS” to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

420 with CNW – What Current Research Says About Marijuana and Memory

We all know the stereotype of the bumbling, forgetful stoner. Cannabis has for long been associated with memory loss, and that has been one of the main arguments against legalizing. However, most of these claims lacked any scientific backing but over the past few years, researchers have been steadily learning more about cannabis and its effect on the human body, especially the brain. To understand how cannabis affects memory, we’ll first have to discuss short and long term memory.

Your short term memory stores immediate events temporarily, for instance, to remember a phone number that has just been recited. It can hold information for approximately twenty to thirty seconds, and it is pushed out when new items are presented. Long term memory, on the other hand, stores information indefinitely. Research has shown that marijuana intoxication does have an effect on short term memory, temporarily altering or distorting short term memory processing.

However, this can’t be blamed on ‘cannabis’ as a whole. The plant produces hundreds of chemicals called cannabinoids, and they are responsible for its effects. In this case, the cannabinoids in question are THC (delta-9 tetrahydrocannabinol) and cannabidiol (“CBD”). When you consume cannabis, these two components disrupt neural signaling by binding with receptors responsible for forming memories in the brain. This can result in problems with concentration, loss of interest, and eventually impact learning.

What’s interesting is that the two cannabinoids have quite different effects. THC, the chemical responsible for cannabis’ infamous high, has a negative effect on short term memory and it increases the risk of developing mental health problems. Cannabidiol, on the other hand, has been found to prevent neural decline. It has a positive impact against neurodegenerative diseases that affect memory such as psychosis, Alzheimer’s, Huntington Chorea, and epilepsy. In fact, some animal studies found that it could prevent the onset of these diseases through the creation of neurons.

There are several different cannabis strains, each with varying levels of CBD and THC, and they have different effects on memory. For instance, cannabis with high levels of THC but little to no CBD will have a negative effect on memory, especially in adolescents. It impacts their ability to retain and recall information, but this isn’t permanent and will stop once you stop consuming cannabis. However, a strain with high CBD levels can prevent neural decline. This goes to show that different types and strains of cannabis can have both positive and negative effects on memory.

The cannabis sector, including entities like Sugarmade, Inc. (OTCQB: SGMD), are glad that the myths against cannabis are being dismantled one at a time by solid scientific data.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

420 with CNW – You Don’t Need Lots of Capital to Be Big in the Marijuana Industry

For many young entrepreneurs, launching a startup is pretty straightforward. Make a snazzy business plan, secure as much funding as you can from investors and hit the ground running. However, acquiring startup capital is no easy task and if you do, you and your business are often at the mercy of your investors and advisory boards. More often than not, these entrepreneurs find themselves running businesses that while successful and profitable, have strayed far from their original visions.

But who said that’s the only way to go? It’s certainly the quicker way, you’ll have funds to make all the appropriate moves early in your business’ inception, but the more funding your receive, the more control you lose. If you go in without much investor funding, it will definitely take you longer to gain some ground, but it’s the best way to build and run your business according to your vision and goals.

Cannabis is a relatively new industry, with most dominant players being only a few years old. So while there are plenty of investors willing to throw their hats into the cannabis industry, few have the experience and insight to help a cannabis startup navigate the industry. Ultimately, deciding whether or not to seek investor funding is a major decision that will have far reaching consequences for your business. So before you do, consider this:

Are you raising capital just to stay afloat or to expand? Similar to how you shouldn’t take a loan to fund a wedding or an expensive car, money from investors should ideally be used to expand and create more opportunities for earning. If you are using funds from investors to stay afloat, you are opening yourself up to major headaches in the near future. Additionally, you should consider how much control you want over the business.

Once you receive investor funding, the business isn’t solely yours. New ideas and opportunities will have to be discussed and agreed upon by all owners before any action. If you have too many investors, it will lead to conflicts over which creative direction to take, and you may find yourself at the helm of a company you don’t recognize. If you don’t go for investor funding, you will have complete control over the business, allowing you to make creative choices free from investor pressure.

These issues connected the implications of investor funding may not be so new to established companies like VIVO Cannabis Inc. (TSX.V: VIVO) (OTCQX: VVCIF) and startups would be well advised to learn from those who have been there before them.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

420 with CNW – Meta Study Finds CBD Could Treat Cocaine Addiction

For the past couple of years, there has been mounting interest in the medical abilities of cannabidiol (“CBD”), a cannabinoid produced by the cannabis plant. This was compounded by the 2018 Farm Bill which legalized industrial hemp and its derivatives and pushed CBD even more into the mainstream. The cannabinoid is said to be effective against a wide range of medical conditions, ranging from certain forms of epilepsy, chronic pain, anxiety, and depression.

A growing body of research has also found that cannabidiol can help treat cocaine addiction. In a new meta-study, scientists analyzed 14 studies from the past five years on the administration of CBD in animal subjects consuming cocaine, and they determined that CBD appears to have a variety of effects that counteract addictive behaviors. The study, published this month in the journal Pharmacology Biochemistry and Behavior states that “CBD promotes reduction on cocaine self-administration. Also, it interferes with cocaine-induced brain reward stimulated and dopamine release.”

“CBD promotes alteration in contextual memory associated with cocaine and in the neuroadaptations, hepatoxicity, and seizures induced by cocaine.” Despite admitting that not all of the studies under review were consistent with each other and stressing on the need for human trials, the researchers said that animal research generally indicated that CBD can reduce self-administration of cocaine and many symptoms of addiction.

For instance, in a study from 2019, researchers reported that “the systemic administration of CBD (20mg/kg) 30 minutes before testing reduced the self-administration of a low dose of cocaine. However, lower concentrations of CBD did not produce the effect. Similarly, a study from 2018 found that a daily 20 mg/kg of CBD led to a “significant difference in the consumption of cocaine on the 10th day of the study and lower consumption throughout the entire procedure compared to the control group of mice.”

A separate study found that administering CBD to rats with a history of cocaine use made them less anxious, as evidenced by “the greater time spent in the open arms of the elevated plus-maze.”

The authors of the new meta-study concluded that “the evidence described in the present systematic review indicated that CBD is a promising adjunct therapy for the treatment of cocaine dependence due to its effect on cocaine consumption, brain reward, anxiety, related contextual memories, neuroadaptations, and hepatic protection as well as its anticonvulsant effect and safety.”

The findings of this research are likely to be welcomed by cannabis companies like Pure Extracts Corp. since the industry has always believed that scientists have barely scratched the surface of the therapeutic effects of cannabis compounds.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

420 with CNW – Montana Activists Say Cannabis Reform Measures Will Be on November Ballot

When the coronavirus pandemic struck, there were tens of marijuana legalization initiatives in states across the country. However, social distancing and self-isolation orders made signature collection virtually impossible and as a result, states such as New York and Idaho have had to postpone their legalization efforts until next year and beyond. Montana, on the other hand, is on track to putting marijuana reform on the ballot this November. On Friday, marijuana activists in the state that based on both county-level signature validation as well as their own verification process, said they were surer they had collected enough signatures to qualify two cannabis reform measures for the November ballot.

Although the coronavirus pandemic initially impeded New Approach Marijuana’s signature collection efforts, the group relaunched their efforts in May with coronavirus related safety measures in place to keep both the signature collectors and the public safe. The group’s revised strategy paid off, and they managed to collect enough valid signatures for a statutory cannabis legalization measure and a separate constitutional amendment that would make a technical change stipulating that only those 21 and older could participate in the market.

The statutory measure, which would establish a regulated cannabis market for adult use in the state, required about 25,000 signatures to qualify for the ballot. New Approach Montana says that 33,000 signatures have been collected and verified. The separate constitutional amendment stipulating that only those 21 and over could participate in the cannabis market required about 51,000 valid signatures and the group collected 52,860 signatures.

According to Pepper Petersen, spokesperson for New Approach Montana, the campaign is “really excited” to have seen such broad support for drug reform in the state. “Every single legislative district submitted signatures to this in Montana. We think that shows a huge level of support out here, and we’re excited going forward. We’re confident that people are going to support this at the ballot as much as they did in the signature-gathering process.”

He says that it was both the commitment of volunteers and the widespread interest in the policy change among voters that led to the campaign’s success. “I think that the success, is of course, our volunteers and our staff were really hard workers and our supporters contributed to that. But it was just the excitement of the Montanans. Montanans want this change and they think it’s well past time for it.”

The Secretary of State has until August 20 to verify to the governor whether the two initiatives will make the ballot. Industry watchers say sector players like Sugarmade, Inc. (OTCQB: SGMD) will be hoping that Montanans finally get to decide whether cannabis should be legal or not during the November polls.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.